LA County Department of Public Health - Tuberculosis Control Program

Publications

Peloquin CA, Berning SE, Nitta AT, Simone PM, Goble M, Huitt GA, Iseman MD, Cook JL, Curran-Everett D. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis 2004;38:1538-1544.

Nitta AT, Kim J. Limited transmission of multidrug-resistant tuberculosis (letter). Am J Respir Crit Care Med 2003;167:473-474.

Oh P, Granich R, Scott J, Sun B, Joseph M, Stringfield C, Thisdell S, Staley J, Workman-Malcolm D, Borenstein L, Lehnkering E, Ryan P, Soukup J, Nitta A, Flood J. Human exposure following Mycobacterium tuberculosis infection of multiple animal species in a metropolitan zoo. Emerg Infect Dis [serial online]2002 Nov;8. Available online from URL: http://www.cdc.gov/ncidod/EID/vol8no11/02-0302.htm

Nitta AT, Knowles LS, Kim J, Lehnkering EL, Borenstein LA, Davidson PT, Harvey SM, de Koning ML. Limited transmission of multidrug-resistant tuberculosis despite a high proportion of infectious cases in Los Angeles County , California . Am J Respir Crit Care Med 2002;165:812-817.

Nitta AT, Milligan D. Management of four pregnant women with multidrug-resistant tuberculosis. Clin Infect Dis 1999;28:1298-1304.

Ridzon R, Whitney CG, McKenna MT, Taylor JP, Ashkar SH, Nitta AT, Harvey SM, Valway S, Woodley C, Cooksey R, Onorato IM. Risk factors for rifampin mono-resistant tuberculosis. Am J Resp Crit Care Med 1998;157:1881-1884.

Nitta AT, Davidson PT, Kilman RJ. Laboratory errors and the misdiagnosis of tuberculosis (letter). JAMA 1997;277:883.

Nitta AT, Davidson PT, de Koning ML, Kilman RJ. Misdiagnosis of multidrug-resistant tuberculosis possibly due to laboratory-related errors. JAMA 1996;276:1980-1983.

Peloquin CA , Nitta AT, Berning SE, Iseman MD, James GT. Pharmacokinetic evaluation of thiacetazone. Pharmacotherapy 1996;16:735-741.

Nitta, AT. Multidrug resistant tuberculosis: how far are we from New York City (epitome). West J Med 1996;165:225-226.

Peloquin CA, Nitta AT, Burman WJ, Brudney KF, Miranda-Massari JR, McGuinness ME, Berning SE, Gerena GT. Incidence of low anti-tuberculosis drug concentrations in patients with AIDS. Ann Pharmacother 1996;30:919-925.

Brown-Harrell V, Nitta AT, Goble M. Exacerbation of vitiligo syndrome due to clofazimine in a patient with pulmonary Mycobacterium avium complex disease (letter) [published erratum appears in Clin Infect Dis 1996;22:1137]. Clin Infect Dis 1996;22:581-582.

Stone MM, Vannier AM, Storch SK , Peterson C, Nitta AT, Zhang Y. Brief report: Meningitis due to iatrogenic BCG infection in two immunocompromised children. N Engl J Med 1995;333:561-563.

Peloquin CA, Henshaw TL, Huitt GA, Berning SE, Nitta AT, James GT. Pharmacokinetic evaluation of para-aminosalicylic acid granules. Pharmacotherapy 1994; 14:40 -46.

Nitta AT, Iseman MD, Newell JD, Madsen LA, Goble M. Ten-year experience with artificial pneumoperitoneum for end-stage, drug-resistant pulmonary tuberculosis. Clin Infect Dis 1993;16:219-222.